Download Engineering of human 3D vascularized tissues including disease

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

12-Hydroxyeicosatetraenoic acid wikipedia , lookup

Epoxyeicosatrienoic acid wikipedia , lookup

Molecular mimicry wikipedia , lookup

Cancer immunotherapy wikipedia , lookup

Immunomics wikipedia , lookup

Innate immune system wikipedia , lookup

Adoptive cell transfer wikipedia , lookup

Transcript
Engineering of human 3D vascularized tissues including disease models
Angela Rossi
To ensure consumer safety, products must be tested for their safety, and efficacy. Although animal models
and two dimensional in vitro models have been widely used, the relevance of these models is limited due
to species specific differences and the lack of cell matrix interactions. As an ethical alternative three
dimensional models mimic the complex in-vivo microenvironment of human tissues and are thus more
predictive for the human situation. However, the applicability of current models is restricted by the lack of
the complex vascular system. Therefore, a biological vascularized scaffold (BioVaSc) based on a
decellularized porcine jejunum was developed that allows the reseeding of the vascular structures,
embedded in the scaffold, with human endothelial cells and the connection of the vascular network with an
outer bloodstream. The BioVaSc can be used as a platform to generate vascularized tissue equivalents e.g.
skin, trachea and intestine models. In addition to the healthy condition of the tissues different diseased
models can be generated using this technology by the addition of tumor cells, pathogens or stimulated
immune cells, which is vital for the development of new effective pharmaceutical products.